Prevalence, etiology, and treatment of depression in Parkinson’s disease
暂无分享,去创建一个
Mahlon R DeLong | William M McDonald | M. Delong | W. McDonald | I. Richard | Irene H Richard | M. DeLong
[1] M. Merello,et al. Depression in classic versus akinetic‐rigid Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.
[2] B. Guze,et al. The etiology of depression in Parkinson's disease patients. , 1991, Psychosomatics.
[3] J. Mink,et al. Clinical features and comorbidity of mood fluctuations in Parkinson's disease. , 2002, The Journal of neuropsychiatry and clinical neurosciences.
[4] S H Lisanby,et al. Transcranial Magnetic Stimulation Applications in Neuropsychiatry , 1999 .
[5] A. Carlsson. Biochemical and pharmacological aspects of Parkinsonism. , 1972, Acta neurologica Scandinavica. Supplementum.
[6] R. Ekman,et al. ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides , 1995, Journal of neural transmission. Parkinson's disease and dementia section.
[7] W. McDonald,et al. Depression and parkinson's disease: a new look at an old problem , 2002, Depression and anxiety.
[8] R. Schiffer,et al. Anxiety and Parkinson's disease. , 1996, The Journal of neuropsychiatry and clinical neurosciences.
[9] K. Jellinger. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms? , 1999, Journal of neural transmission. Supplementum.
[10] R. Hauser,et al. Sertraline for the treatment of depression in parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.
[11] B. Bergamasco,et al. Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[12] W. Burke,et al. Maintenance electroconvulsive therapy for intractable Parkinson's disease. , 1998, The American journal of geriatric psychiatry.
[13] Dwight L. Evans,et al. Comparison of pramipexole, fluoxetine, and placebo in patients with major depression , 2000, Depression and anxiety.
[14] I. Richard,et al. Relationship between mood and motor fluctuations in Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.
[15] E. Lauterbach,et al. Clinical, motor, and biological correlates of depressive disorders after focal subcortical lesions. , 1997, The Journal of neuropsychiatry and clinical neurosciences.
[16] O. Blin,et al. Does fluoxetine aggravate Parkinson's disease? A pilot prospective study , 1995, Movement disorders : official journal of the Movement Disorder Society.
[17] M. Åsberg,et al. A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.
[18] R G Robinson,et al. Depression in Parkinson's Disease , 1990, The Journal of nervous and mental disease.
[19] David Eidelberg,et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. , 2002, The American journal of psychiatry.
[20] W. McDonald,et al. Magnetic resonance in patients with affective illness , 2005, European Archives of Psychiatry and Clinical Neuroscience.
[21] P. Strick,et al. Basal Ganglia Output and Cognition: Evidence from Anatomical, Behavioral, and Clinical Studies , 2000, Brain and Cognition.
[22] Y Agid,et al. Transient acute depression induced by high-frequency deep-brain stimulation. , 1999, The New England journal of medicine.
[23] D. Aarsland,et al. Maintenance electroconvulsive therapy for Parkinson's disease. , 1997, Convulsive therapy.
[24] J. Sage,et al. Depression and Anxiety in Parkinson's Disease: Possible Effect of Genetic Variation in the Serotonin Transporter , 1999, Journal of geriatric psychiatry and neurology.
[25] H. Mayberg,et al. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[26] R. Mayeux,et al. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. , 1993, Archives of neurology.
[27] P. Madeley,et al. Cognitive impairments and depression in Parkinson ' s disease , 2022 .
[28] P. Shvartzman,et al. Parkinson's disease camouflaging early signs of hypothyroidism. , 1993, Postgraduate medicine.
[29] L. Judd,et al. Subsyndromal symptomatic depression: a new mood disorder? , 1994, The Journal of clinical psychiatry.
[30] H. Meltzer,et al. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant , 1979, Journal of Neural Transmission.
[31] V. Kostic,et al. Effect of age at onset on frequency of depression in Parkinson's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[32] S. Chiechio,et al. The SSRI, Citalopram, Improves Bradykinesia in Patients With Parkinson's Disease Treated with L-Dopa , 2002, Clinical neuropharmacology.
[33] L. Judd. Subsyndromal Symptomatic Depression , 1994 .
[34] Cheng‐Huai Lin,et al. The correlation of depression with functional activity in Parkinson’s disease , 1997, Journal of Neurology.
[35] W. Weiner,et al. Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[36] William W. McDonald,et al. Neuropsychological and psychiatric sequelae of pallidotomy for PD: Clinical trial findings , 2002, Neurology.
[37] J. Cummings,et al. The occurrence of depression in Parkinson's disease. A community-based study. , 1996, Archives of neurology.
[38] R. Leiguarda,et al. Cognitive functions in major depression and Parkinson disease. , 1997, Archives of neurology.
[39] I. Richard,et al. Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series , 1999, Movement disorders : official journal of the Movement Disorder Society.
[40] M. Mark,et al. Parkinson's disease and depression: the relationship to disability and personality. , 1994, The Journal of neuropsychiatry and clinical neurosciences.
[41] Plaut Ea. Fourier's view on homosexuality. , 1989 .
[42] K. Krishnan,et al. In vivo stereological assessment of caudate volume in man: effect of normal aging. , 1990, Life sciences.
[43] H. Przuntek,et al. Elevated Plasma Levels of Homocysteine inParkinson’s Disease , 1998, European Neurology.
[44] H. Ross,et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease , 2000, Neurology.
[45] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[46] J. Rabkin,et al. Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. , 1998, Journal of affective disorders.
[47] J. Nutt,et al. Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: Preliminary findings , 1995, Movement disorders : official journal of the Movement Disorder Society.
[48] H. Reichmann,et al. Parkinson’s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography , 1997, Journal of neurology, neurosurgery, and psychiatry.
[49] Y. Hishikawa,et al. Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[50] R. Mayeux,et al. Altered serotonin metabolism in depressed patients with Parkinson's disease , 1984, Neurology.
[51] S. Gershon,et al. Dopamine and depression , 2005, Journal of Neural Transmission / General Section JNT.
[52] M. Okun,et al. Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. , 2002, Archives of neurology.
[53] P. Riederer,et al. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease , 2001, Molecular Psychiatry.
[54] A. Tröster,et al. Neuropsychological impairment in Parkinson's disease with and without depression. , 1995, Archives of neurology.
[55] M. O’Connor,et al. Effectiveness of ECT in patients with parkinsonism. , 1998, The Journal of neuropsychiatry and clinical neurosciences.
[56] K. Mewes,et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. , 2001, Brain : a journal of neurology.
[57] L. George,et al. Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. , 1997, The American journal of psychiatry.
[58] R. Robinson,et al. Dementia of Depression in Parkinson's Disease and Stroke , 1991, The Journal of nervous and mental disease.
[59] R. Cantello,et al. Applications of Transcranial Magnetic Stimulation in Movement Disorders , 2002, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[60] R. Hales,et al. J Neuropsychiatry Clin Neurosci , 1992 .
[61] M. Martens,et al. Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.
[62] L. Murri,et al. Paroxetine in Parkinson’s disease: Effects on motor and depressive symptoms , 2000, Neurology.
[63] J. Saint-Cyr,et al. Parkinson's disease and depression. A critical re-evaluation. , 1986, Brain : a journal of neurology.
[64] Tenover Jl. Testosterone and the Aging Male , 1997 .
[65] F. Verhey,et al. The validity of the Hamilton and Montgomery‐Åsberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease , 2000, International journal of geriatric psychiatry.
[66] T. Bottiglieri,et al. S‐adenosyl‐methionine improves depression in patients with Parkinson's disease in an open‐label clinical trial , 2000, Movement disorders : official journal of the Movement Disorder Society.
[67] Nir Giladi,et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease , 2000, Journal of Neural Transmission.
[68] E. Youngstrom,et al. Depression and disability in Parkinson's disease. , 1996, The Journal of neuropsychiatry and clinical neurosciences.
[69] H. Allain,et al. Depression in Parkinson's disease , 2000, BMJ : British Medical Journal.
[70] D. V. von Cramon,et al. In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.
[71] K. Wells,et al. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. , 1996, The American journal of psychiatry.
[72] S H Lisanby,et al. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. , 1993, Journal of neural transmission. Supplementum.
[73] H. Groenewegen,et al. Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat , 1990, The Journal of comparative neurology.
[74] Jens Volkmann,et al. Depression and Parkinson’s disease , 2004, Journal of Neurology.
[75] D. Aarsland,et al. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study , 2002, Journal of neurology, neurosurgery, and psychiatry.
[76] J. Friedman,et al. Does fluoxetine exacerbate Parkinson's disease? , 1992, The Journal of clinical psychiatry.
[77] R. Mayeux,et al. Coexisting dementia and depression in Parkinson's disease. , 1989, Archives of neurology.
[78] L. Laitinen. DESIPRAMINE IN TREATMENT OF PARKINSON'S DISEASE , 1969 .
[79] A. Lees,et al. On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study. , 1984, Brain : a journal of neurology.
[80] M. Okun,et al. Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity. , 2002, Archives of neurology.
[81] J. Cummings. Depression and Parkinson's disease: a review. , 1992, The American journal of psychiatry.
[82] M. Marmot,et al. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? , 1995, Journal of neurology, neurosurgery, and psychiatry.
[83] M. Lawton,et al. Depression and Medical Illness in Late Life: Report of a Symposium , 1996, Journal of the American Geriatrics Society.
[84] J. Villemure,et al. Effect on mood of subthalamic DBS for Parkinson’s disease A consecutive series of 24 patients , 2002, Neurology.
[85] H Helenius,et al. The quality of life in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[86] C. Marsden,et al. Depression and disability in Parkinson's disease: a follow-up of 132 cases , 1988, Psychological Medicine.
[87] R. Duvoisin,et al. Mood changes and “on‐off” phenomena in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.
[88] Dc Washington. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .
[89] R. Kelley,et al. Thyroid function in Parkinson disease , 1981, Neurology.
[90] J. Cummings,et al. Risk factors for depression in Parkinson disease. , 1997, Archives of neurology.
[91] J. Hesselink. Serotonin and Parkinson's disease. , 1993, The American journal of psychiatry.
[92] R. Mayeux,et al. The "serotonin hypothesis" for depression in Parkinson's disease. , 1990, Advances in neurology.
[93] V. Kostic,et al. Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: An open study , 2002, Movement disorders : official journal of the Movement Disorder Society.
[94] Cristina Tassorelli,et al. Functional changes of the basal ganglia circuitry in Parkinson's disease , 2000, Progress in Neurobiology.
[95] H. Mayberg,et al. Cognitive impairments and depression in Parkinson's disease: a follow up study. , 1990, Journal of neurology, neurosurgery, and psychiatry.
[96] J. Cummings,et al. Parkinson's disease, depression, and the on-off phenomenon. , 1989, Psychosomatics.
[97] C. Tanner,et al. Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease , 1997, Neurology.
[98] J. Marinus,et al. The contribution of somatic symptoms to the diagnosis of depressive disorder in Parkinson's disease: a discriminant analytic approach. , 2003, The Journal of neuropsychiatry and clinical neurosciences.
[99] Maurizio Fava,et al. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. , 2002, The American journal of clinical nutrition.
[100] C. Mariani,et al. Tolerability of paroxetine in Parkinson's disease: A prospective study , 2000, Movement disorders : official journal of the Movement Disorder Society.
[101] H. Przuntek,et al. The motor performance test series in Parkinson's disease is influenced by depression , 2005, Journal of Neural Transmission.
[102] W. Kuhn,et al. Nigral endothelial dysfunction, homocysteine, and Parkinson's disease , 1999, The Lancet.
[103] R. Mayeux,et al. Depression, intellectual impairment, and Parkinson disease , 1981, Neurology.
[104] H. Mayberg,et al. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease , 1990, Annals of neurology.
[105] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[106] B. Toone,et al. Homocysteine, folate, methylation, and monoamine metabolism in depression , 2000, Journal of neurology, neurosurgery, and psychiatry.
[107] C. Marsden,et al. Mood swings associated with the ‘on—off’ phenomenon in Parkinson's disease , 1987, Psychological Medicine.
[108] C. Tanner,et al. Bupropion in Parkinson's disease , 1984, Neurology.
[109] F. Verhey,et al. The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[110] G. Dell''Agnello,et al. SSRIs Do Not Worsen Parkinson's Disease: Evidence from an Open-Label, Prospective Study , 2001, Clinical neuropharmacology.
[111] K. Jellinger,et al. The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease , 1991, Journal of neuropathology and experimental neurology.
[112] E. Caine,et al. The Importance of Subsyndromal Depression in Older Primary Care Patients: Prevalence and Associated Functional Disability , 1999, Journal of the American Geriatrics Society.
[113] M. Weissman,et al. Depressive symptoms as relative and attributable risk factors for first-onset major depression. , 1992, Archives of general psychiatry.
[114] V. Lerner,et al. Successful Use of Donepezil for the Treatment of Psychotic Symptoms in Patients With Parkinson's Disease , 2002, Clinical neuropharmacology.
[115] E. N. Steur,et al. Increase of Parkinson disability after fluoxetine medication. , 1993, Neurology.
[116] Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD. , 2000, Neurology.
[117] E. Barrett-Connor,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Bioavailable Testosterone and Depressed Mood in Older Men: The Rancho Bernardo Study , 2022 .
[118] F. Jiménez-Jiménez,et al. Parkinsonism exacerbated by paroxetine , 1994, Neurology.
[119] J. Andersen,et al. Anti‐depressive treatment in Parkinson's disease A CONTROLLED TRIAL OF THE EFFECT OF NORTRIPTYLINE IN PATIENTS WITH PARKINSON'S DISEASE TREATED WITH L‐DOPA , 1980, Acta neurologica Scandinavica.
[120] R. Beninger,et al. Depressive Symptoms in Parkinson's Disease: A Comparison With Disabled Control Subjects , 1990, Journal of geriatric psychiatry and neurology.
[121] Fabrizio Stocchi,et al. Factors impacting on quality of life in Parkinson's disease: Results from an international survey , 2002, Movement disorders : official journal of the Movement Disorder Society.
[122] Y. Oiso,et al. Hypothalamic dysfunction in Parkinson's disease patients. , 1994, Acta medica Hungarica.
[123] R. Strang. Imipramine in Treatment of Parkinsonism: a Double-blind Placebo Study , 1965, British medical journal.
[124] A. Granérus,et al. Maintenance ECT in Parkinson's disease , 1999, Journal of Neural Transmission.
[125] Zafiris J Daskalakis,et al. Transcranial magnetic stimulation: a new investigational and treatment tool in psychiatry. , 2002, The Journal of neuropsychiatry and clinical neurosciences.
[126] Tate Jl. Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine. , 1989 .
[127] T. Müller. Non-dopaminergic drug treatment of Parkinson’s disease , 2001, Expert opinion on pharmacotherapy.
[128] K. Marder,et al. An estimate of the incidence of depression in idiopathic Parkinson's disease. , 1992, Archives of neurology.
[129] L. Metman,et al. Fluoxetine in Parkinson's disease , 1996, Movement disorders : official journal of the Movement Disorder Society.
[130] C. Reynolds,et al. Minor and Subsyndromal Depression: Functional Disability Worth Treating , 1999, Journal of the American Geriatrics Society.
[131] W. Katon,et al. Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. , 2000, JAMA.
[132] K. Marder,et al. Antecedent clinical features associated with dementia in Parkinson's disease , 1993, Neurology.
[133] P. Sachdev,et al. Homocysteine in neuropsychiatric disorders of the elderly , 2002, International journal of geriatric psychiatry.